Ill. provider cleared in class-action lawsuit from breach

Advocate Medical Group has been cleared of wrongdoing in a class action lawsuit alleging the organization failed to protect patient data following a massive HIPAA data breach.

The decision was filed August 6 by the Appellate Court of Illinois Second District and affirmed two previous court dismissals of the complaints. The Chicago-based Advocate faced the lawsuit filed by former patients alleging that they faced "an increased risk of identity theft and/or identity fraud" after four unencrypted AHC laptops containing patient data were stolen from one of its medical facilities in July 2013.

The stolen laptops contained the Social Security numbers and protected health information, including medical diagnoses, of 4,029,530 patients, making it the sixth largest HIPAA breach ever reported, according to data from the Department of Health and Human Services.

"We reject plaintiffs' arguments and note again that their allegations are merely speculative," Illinois Appellate Judge Ann B. Jorgensen ruled. "The fact that two plaintiffs to date (out of those four million) have received notification of fraudulent activity, i.e., have suffered actual injury arising from Advocate's alleged wrongful acts, does not show that plaintiffs here face imminent, certainly impending, or a substantial risk of harm as a result of the burglary, where no such activity has occurred with respect to their personal data."

The appellate panel affirmed two previous court dismissals of the case, both of which argued that there was no "present harm" or that "the harm that Plaintiffs fear is contingent on a chain of attenuated hypothetical events and actions by third parties."

 

Beth Walsh,

Editor

Editor Beth earned a bachelor’s degree in journalism and master’s in health communication. She has worked in hospital, academic and publishing settings over the past 20 years. Beth joined TriMed in 2005, as editor of CMIO and Clinical Innovation + Technology. When not covering all things related to health IT, she spends time with her husband and three children.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.